AuntMinnie

MAY 8, 2024

Theranostics treatments are used with increasing frequency now since the approvals and expansions of Lutathera (lutetium-177 [Lu-177]) DOTATATE, a radiopharmaceutical for neuroendrocrine tumors (NETs) and Pluvicto, Lu-177 PSMA-617, for prostate cancer. Extravasations Extravasations, in particular, are of interest to the U.S.

Radiopharmaceuticals 189

Radiopharmaceuticals Nuclear Medicine Radiation Hospital 189

AuntMinnie

JANUARY 16, 2025

Oliverio joins Actineer with over 30 years of leadership experience across the nuclear medicine, medical device, and radiopharmaceutical industries, including roles at Ionetix, Imagin Molecular, and Positron.

Nuclear Medicine 130

Nuclear Medicine Medical Device Radiopharmaceuticals Medical 130

AuntMinnie

JULY 10, 2024

Centers for Medicare and Medicaid Services (CMS) proposed a new reimbursement plan July 10 for diagnostic PET scans that would provide separate payments for radiopharmaceuticals, as well as an extra payment for hospitals when they use domestically produced technetium-99m (Tc-99m).

Nuclear Medicine 305

Nuclear Medicine Radiopharmaceuticals Imaging Medicare 305

AuntMinnie

SEPTEMBER 13, 2023

The Medical Imaging and Technology Alliance (MITA) has raised concerns ove. Senate MITA hails radiopharmaceutical legislation

Radiopharmaceuticals 130

Radiopharmaceuticals PET Scan Medical Imaging Disease 130

Open Medscience

SEPTEMBER 25, 2024

Regulatory radiopharmaceutical production requires strict adherence to safety standards, ensuring quality and patient safety. The post Regulatory Considerations in Radiopharmaceutical Production appeared first on Open MedScience.

Radiopharmaceuticals 105

Radiopharmaceuticals Patient Safety Medical 105

AuntMinnie

JULY 12, 2024

Reshaping the hospital's nuclear medicine and radiopharmaceutical strategy toward theranostics involves intensive and inclusive planning, Beyder explained at SNMMI. Spending time on electronic medical record (EMR) system order sets early will translate into higher reimbursement. Also be mindful of design requirements in the U.S.;

Nuclear Medicine 264

Nuclear Medicine Radiation Oncology Radiopharmaceuticals Radiation 264

AuntMinnie

JUNE 3, 2024

With therapeutic radiopharmaceuticals coming to market quickly and available to smaller institutions around the U.S., My vision of a theranostic center includes a flagship facility that has a PET/CT scanner, a SPECT/CT scanner, and then multiple rooms for infusions of radiopharmaceuticals," Siegel explained.

Nuclear Medicine 264

Nuclear Medicine Radiopharmaceuticals Radiation Radiation Oncology 264

AuntMinnie

MARCH 7, 2024

In terms of 2023 spending, the average radiopharmaceutical expenditure per fixed PET site is estimated to be $517,000. Want to share your knowledge of medical imaging? Davin Korstjens is a Senior Market Research Program Manager at IMV Medical Information Division, part of Science and Medicine Group.

PET Scan 290

PET Scan Nuclear Medicine Radiation Oncology Radiopharmaceuticals 290

AuntMinnie

JUNE 11, 2024

TORONTO – The radiopharmaceutical Pluvicto improves progression-free survival in patients with metastatic prostate cancer who haven’t undergone taxane therapy, according to research presented at the SNMMI meeting. Oliver Sartor, MD The study, which was awarded SNMMI’s Abstract of the Year award, shared data from the phase III PSMAfore trial.

Nuclear Medicine 306

Nuclear Medicine Radiopharmaceuticals Radiographer Radiographer 306

AuntMinnie

NOVEMBER 12, 2024

He earned his medical degree at the University of Alabama School of Medicine and completed a residency in diagnostic radiology at the University of Florida. Her research focuses on predictive modeling in AI, clinical decision support, medical image processing, clinical problem-solving, and decision-making. "My from Ukraine.

Radiologist 360

Radiologist Education Clinic Radiology 360

AuntMinnie

JANUARY 8, 2024

Alpha-9 Oncology and NorthStar Medical Radioisotopes have entered into a supply agreement under which NorthStar will provide Alpha-9 with actinium-225. NorthStar will be one of the first commercial-scale producers of actinium-225 for clinical research and commercial radiopharmaceutical therapy, Alpha-9 said.

Medical 130

Medical Radiopharmaceuticals Clinic Radiology 130

Open Medscience

NOVEMBER 17, 2023

Gallium, predicted by Mendeleev, now revolutionises medical diagnostics with its unique radiopharmaceutical applications in oncology. The post Gallium Radiopharmaceuticals in Medical Imaging appeared first on Open Medscience.

Radiopharmaceuticals 59

Radiopharmaceuticals Medical Imaging Medical Imaging 59

Imaging Technology

JULY 25, 2024

mtaschetta-millane Thu, 07/25/2024 - 08:50 July 25, 2024 — NorthStar Medical Radioisotopes, LLC and BWXT Medical Ltd. , Medical isotopes are essential for a wide range of diagnostic and therapeutic procedures, including cancer treatments and advanced imaging techniques. a subsidiary of BWX Technologies, Inc.

Medical 105

Medical Radiopharmaceuticals Pharmaceutical Clinic 105

Open Medscience

NOVEMBER 12, 2023

Technetium-99m, discovered in 1937, transformed medical imaging with its versatile and safe diagnostic applications. The post Technetium-99m Radiopharmaceuticals in Advanced Medical Imaging appeared first on Open Medscience.

Radiopharmaceuticals 59

Radiopharmaceuticals Medical Imaging Medical Imaging 59

AuntMinnie

JULY 29, 2024

billion proposal by the Netherlands to fund construction of a new medical isotope production facility in Petten. The new so-called Pallas reactor will replace the existing high flux reactor, one of the world leaders in the production of medical isotopes, in operation since 1961, the commission said, in a July 26 statement.

Medical 130

Medical Nuclear Medicine Radiopharmaceuticals Disease 130

Imaging Technology

SEPTEMBER 20, 2023

milla1cf Wed, 09/20/2023 - 09:56 September 20, 2023 — RefleXion Medical , Inc., Using its technology platform, 3BP has discovered and characterized a large portfolio of FAP-targeting molecules as potential diagnostic and therapeutic radiopharmaceuticals. chief business officer at RefleXion.

Pharmaceutical 105

Pharmaceutical Radiopharmaceuticals Radiation Diagnostic 105

Imaging Technology

JANUARY 5, 2024

This leading radiopharmaceutical platform provides detailed PET imaging-based diagnosis and dosimetry using long-lived copper-64 ( 64 Cu) for imaging and alpha-particle targeted RPT using lead-212 ( 212 Pb). milla1cf Fri, 01/05/2024 - 11:21 January 5, 2024 — Perspective Therapeutics, Inc.

Radiopharmaceuticals 104

Radiopharmaceuticals Clinic Nuclear Medicine Radiation 104

AuntMinnie

FEBRUARY 11, 2025

United Theranostics has secured $15 million in funding from Old National Bank to expand its network of radiopharmaceutical therapy clinics for cancer treatment. United Theranostics offers patients-approved radiopharmaceutical therapies and clinical trials for new radiopharmaceutical drugs under investigation.

Radiopharmaceuticals 147

Radiopharmaceuticals Clinic Medical IT 147

Imaging Technology

APRIL 10, 2024

an investigational radiohybrid (rh) Prostate-Specific Membrane Antigen-targeted therapeutic radiopharmaceutical, is the lead candidate in Blue Earth Therapeutics’ oncology development program of next generation therapeutic radiopharmaceuticals. 177Lu-rhPSMA-10.1, Gauden , D.Phil., Chief Executive Officer of Blue Earth Therapeutics.

Radiopharmaceuticals 105

Radiopharmaceuticals Radiosensitivity Medical Diagnostic 105

AuntMinnie

DECEMBER 11, 2023

Key corporate members and staff from the Medical Imaging Technology Alliance (MITA) are launching a new medical imaging technology division at medical technology trade association Advanced Medical Technology Association (AdvaMed).

Imaging 278

Imaging Medical Imaging Radiopharmaceuticals Medical 278

Open Medscience

JANUARY 12, 2024

Radiopharmaceuticals, combining radioactive and pharmaceutical elements, enable precise diagnosis and treatment in nuclear medicine. The post The Transformative Impact of Radiopharmaceuticals in Medical Imaging appeared first on Open Medscience.

Radiopharmaceuticals 52

Radiopharmaceuticals Medical Imaging Nuclear Medicine Medical 52

Imaging Technology

APRIL 13, 2023

He has more than 22 years of operational and commercial expertise in radioisotopes and radiopharmaceuticals. actinium-225 (Ac-225), and drive business development initiatives for NorthStar’s Radiopharmaceutical CDMO/CMO business units. Ac-225 and Cu-67 using environmentally preferable technologies.

Radiopharmaceuticals 97

Radiopharmaceuticals Medical Pharmaceutical Nuclear Medicine 97

AuntMinnie

OCTOBER 25, 2024

He earned his medical degree at the University of Alabama School of Medicine and completed a residency in diagnostic radiology at the University of Florida. Pickhardt serves as chief of gastrointestinal imaging at the University of Wisconsin in Madison and is medical director of oncological imaging at the UW Carbone Cancer Center.

Nuclear Medicine 358

Nuclear Medicine Education Radiology Technologist Radiation Science 358

AuntMinnie

MARCH 26, 2025

Centers for Medicare and Medicaid (CMS) to update the Hospital Outpatient Prospective Payment System (HOPPS) in 2025 by unbundling radiopharmaceuticals. Bera (D-CA) worked to include report language that promotes nuclear medicine research in the Department of Defenses (DOD) Congressionally Directed Medical Research Programs ( CDMRP ).

Nuclear Medicine 130

Nuclear Medicine Radiopharmaceuticals Medicare Diagnostic 130

AuntMinnie

DECEMBER 8, 2023

Suspicion of malignancy may be prompted by avid uptake of the radiopharmaceutical FDG on PET/CT imaging, according to study results delivered on November 27 at the RSNA meeting. Accurate diagnosis of organizing pneumonia is confounded by the co-existence of [the condition] with lung malignancies," Kim said.

Imaging 309

Imaging Radiopharmaceuticals Disease Diagnose 309

Imaging Technology

APRIL 3, 2023

NorthStar’s industry-leading reputation is grounded in technological innovation, successful execution and proven expertise, and we have made tremendous strides in advancing our portfolio over the past year,” said Stephen Merrick , Chief Executive Officer of NorthStar Medical Radioisotopes.

Medical 98

Medical Radiopharmaceuticals Pharmaceutical Radiation 98

AuntMinnie

JUNE 6, 2024

million that it will use to develop its radiopharmaceutical pipeline and prepare for the potential launch of ITM-11. The company added that it also aims to expand ITM's manufacturing capabilities to new, high-value medical radioisotopes including actinium-225. Isotope Technologies Munich (ITM) has secured an equity investment of $204.6

Radiopharmaceuticals 130

Radiopharmaceuticals Medical IT 130

AuntMinnie

MARCH 26, 2024

Food and Drug Administration's (FDA) approvals of radiopharmaceuticals for neuroendocrine tumors and then for prostate cancer, theranostics has picked up momentum in clinical practice, propelled by encouraging research. Since 2013 we've had several more radiopharmaceutical therapies get FDA approval. Since the U.S.

Nuclear Medicine 306

Nuclear Medicine Radiopharmaceuticals Radiation Health Science 306

AuntMinnie

JANUARY 17, 2025

At-211's usage is generally limited to select geographic areas near academic and medical centers where the isotope is produced in small batches, Nusano noted. The collaboration involves Nusanos new 170,000-square-foot radioisotope production facility in West Valley City, UT, which is expected to open in 2025.

Radiopharmaceuticals 130

Radiopharmaceuticals Clinic Medical IT 130

AuntMinnie

JUNE 5, 2024

NorthStar Medical Radioisotopes has completed a cleanroom facility at its campus in Beloit, WI, to support batch production of radiopharmaceuticals for research and treatment. The cleanroom at NorthStar's campus in Beloit, WI.

Radiopharmaceuticals 130

Radiopharmaceuticals Clinic Medical IT 130

AuntMinnie

APRIL 15, 2024

Davin Korstjens of IMV Medical Information Division. According to the report, this year 14% of nuclear medicine sites are currently performing theranostics procedures, with the top two radiopharmaceuticals used being Y-90 microspheres and iodine-131. Total nuclear medicine patient study volumes decreased by 5.7% Nonhospitals 2.5%

Nuclear Medicine 279

Nuclear Medicine Hospital Radiopharmaceuticals Radiologist 279

Imaging Technology

APRIL 24, 2023

milla1cf Mon, 04/24/2023 - 14:10 April 24, 2023 — - NorthStar Medical Radioisotopes , LLC, a global innovator in the development, production and commercialization of radiopharmaceuticals used for therapeutic and medical imaging applications, has announced the appointment of Jean-Noel David , MBA, MS, as Vice President, Operations.

Medical 98

Medical Radiopharmaceuticals Pharmaceutical Government 98

Open Medscience

JANUARY 1, 2024

Zirconium radiopharmaceuticals enhance nuclear medicine with precise diagnostics and potential therapeutic applications. The post Zirconium Radiopharmaceuticals in Nuclear Medicine appeared first on Open Medscience.

Nuclear Medicine 59

Nuclear Medicine Radiopharmaceuticals Diagnostic Medical 59

AuntMinnie

FEBRUARY 19, 2025

Food and Drug Administration (FDA) for its copper-67 (Cu-67) SAR-bisPSMA radiopharmaceutical for treating advanced prostate cancer. The radiopharmaceutical and imaging agent are a theranostics pair in development for use in patients from initial to late-stage disease, the company noted.

Radiopharmaceuticals 130

Radiopharmaceuticals Pharmaceutical Disease Diagnostic Imaging 130

Imaging Technology

JUNE 19, 2023

milla1cf Mon, 06/19/2023 - 19:27 June 19, 2023 — NorthStar Medical Technologies, LLC , a global innovator in the development, production and commercialization of radiopharmaceuticals used for therapeutic applications and medical imaging, today announced the appointment of Frank Scholz, Ph.D., NorthStar’s commercialized, U.S.-based

Medical 98

Medical Pharmaceutical Radiopharmaceuticals Nuclear Medicine 98

Open Medscience

JULY 28, 2019

Radiopharmaceuticals are used in nuclear medicine for the application of medical imaging and therapy. The post Radiopharmaceuticals used in nuclear medicine appeared first on Open Medscience.

Nuclear Medicine 52

Nuclear Medicine Radiopharmaceuticals Medical Imaging Medical 52

AuntMinnie

APRIL 4, 2024

The RLS radiopharmacy network will use these generators to produce gallium-68-based (Ga-68) radiopharmaceuticals for PET imaging and treatment planning for patients with neuroendocrine tumors and prostate cancer. RLS added that it is also building a national distributed radiopharmaceutical contract development and manufacturing network.

Radiopharmaceuticals 130

Radiopharmaceuticals Medical IT Imaging 130